Gestational diabetes, preeclampsia and cytokine release: Similarities and differences in endothelial cell function

Advances in Experimental Medicine and Biology

Volumn 814, Issue , 2014, Pages 69-75

  Rao, Rashmi ^a,b   Sen, Suvajit ^a,b   Han, Bing ^a,b   Ramadoss, Sivakumar ^a,b   Chaudhuri, Gautam ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelial dysfunction; Gestational diabetes; Hyperglycemia; Pre eclampsia

Indexed keywords

C REACTIVE PROTEIN; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TRICARBOXYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE;

ADIPOSE TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENERGY YIELD; ENZYME ACTIVITY; GLYCOLYSIS; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; IMMUNOPATHOGENESIS; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE MIGRATION; MATERNAL DISEASE; MATERNAL INFECTION; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; FEMALE; IMMUNOLOGY; METABOLISM; PREGNANCY COMPLICATION; VASCULAR ENDOTHELIUM;

CYTOKINES; DIABETES, GESTATIONAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84921683969     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1031-1_6     Document Type: Article

References (35)

1. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol. 2004;103:526-33.
2. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia. 1998;41:904-10.
3. Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am. 2007;34:213-24.
4. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241: 2035-8.
5. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabeti c subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.
6. Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJ, Stehouwer CD, et al. Endothelial d ysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord. 2013;14:39-48.
7. Venkatesan B, Valente AJ, Das NA, Carpenter AJ, Yoshida T, Delafontaine JL, et al. CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction. Cell Signal. 2013;25:359-71.
8. Sobrevia L, Mann GE. Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol. 1997;82:423-52.
9. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, et al. Acute hyperglycemia at tenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;197:1695-701.
10. Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, Syriou V, et al. Cy tokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol. 2008;28:314-21.
11. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care. 2002;5:551-9.
12. Kyselova P, Zourek M, Rusavy Z, Trefil L, Racek J. Hyperinsulinemia and oxidative stress. Physiol Res. 2002;51:591-5.
13. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143-59.
14. Jansson PA. Endothelial dys function in insulin resistance and type 2 diabetes. J Intern Med. 2007; 262:173-83.
15. Wolff SP,Jiang ZY,Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing Free Radic Biol Med. 1991 10,339-52.
16. Eriksson UJ, Borg LA. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes. 1993;42:411-9.
17. Cai S, Khoo J, Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res. 2005;65:823-31.
18. Giacco F, Brown lee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058-70.
19. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008;12:223-42.
20. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198:7-22.
21. Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-Alpha in whole blood cultures of preeclamptic patients and healthy pregnan t and nonpregnant women. Hypertens Pregnancy. 2004;23:319-29.
22. Sulbaran TA, Castellano A, Chacin L, Vergel C, Portillo MA, Urbina E, et al. Electron microscopy of umbilical cord en dothelial cells in preeclampsia. J Submicrosc Cytol Pathol. 2002;34:389-95.
23. Peters K, Kamp G, Berz A, Unger RE, Barth S, Salamon A, et al. Changes in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of " aerobic glycolysis" and proliferation. Cell Physiol Biochem. 2009;24:483-92.
24. La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, M olinatti GM, et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetolog ia. 1996;39:1263-8.
25. Quintero M, Colombo SL, Godfrey A, Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A. 2006;103: 5379-84.
26. Feig SA, Segel GB, Shohet SB, Nathan DG. Energy metabolism in human erythrocytes. II. Effects of glucose depletion. J Clin Invest. 1972;51:1547-54.
27. Janzen C, Sen S, Cuevas J, Reddy ST, Chaudhuri G. Protein phosphatase 2A promotes endothelial survival via stabilization of translational inhibitor 4E-BP1 following exposure to tumor necrosis factor-α. Arterioscler Thromb Vasc Biol. 2011;31:2586-94.
28. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res. 1994;214:584-94.
29. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol. 1999;31:61-74.
30. Yoshizumi M, Perrella MA, Burnett Jr. JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its halflife. Circ Res. 1993;73:205-9.
31. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin leve ls enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 1994;93:2236-43.
32. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol. 2001;280:F480-6.
33. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834-8.
34. Xu B, Ji Y, Yao K, Cao YX, Ferro A. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes. Clin Sci (Lond). 2005;109:439-46.
35. Falavigna M, Schmidt MI, Trujillo J, Alves LF, Wendland ER, Torloni MR, et al. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract. 2012;98:396-405.